Suppr超能文献

混合细胞型肝癌的主要成分的意义:MRI 表现与预后价值。

The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value.

机构信息

Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Department of Radiology, Zhongshan Hospital (Xiamen), Fudan University, Shanghai , 361006, Fujian, China.

出版信息

Radiol Med. 2023 Sep;128(9):1047-1060. doi: 10.1007/s11547-023-01682-x. Epub 2023 Jul 20.

Abstract

PURPOSE

To investigate the significance of the predominant component of combined hepatocellular-cholangiocarcinoma (cHCC-CC) in terms of MRI manifestation and its potential prognostic value compared to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).

MATERIALS AND METHODS

A total of 300 patients with chronic liver disease from two centers were retrospectively enrolled, including 100 surgically proven cases of cHCC-CC, HCC, and ICC each. Univariate and multivariate regression analyses were performed to identify independent predictors for distinguishing HCC-predominant cHCC-CC and ICC-predominant cHCC-CC from HCC and ICC, respectively. Diagnostic models were constructed based on the independent features. Recurrence-free survival (RFS) was estimated and compared between groups.

RESULTS

The predominant component was an independent predictor for RFS in cHCC-CC (hazard ratio = 1.957, P = 0.044). The presence of targetoid appearance (odds ratio(OR) = 10.907, P = 0.001), lack of enhancing capsule (OR = 0.072, P = 0.001) and arterial peritumoral enhancement (OR = 0.091, P = 0.003) were independent predictors suggestive of HCC-predominant cHCC-CC over HCC; their combination yielded an area under the curve of 0.756. No significant differences were observed in RFS between HCC-predominant cHCC-CC and HCC (P = 0.864). Male gender (OR = 4.049, P = 0.015), higher alpha fetoprotein (OR = 16.789, P < 0.001) and normal carbohydrate antigen 19-9 (OR = 0.343, P = 0.036) levels, presence of enhancing capsule (OR = 7.819, P < 0.001) and hemorrhage (OR = 23.526, P = 0.004), and lack of targetoid appearance (OR = 0.129, P = 0.005) and liver surface retraction (OR = 0.190, P = 0.021) were independent predictors suggestive of ICC-predominant cHCC-CC over ICC; their combination yielded an area under the curve value of 0.898. ICC-predominant cHCC-CC exhibited poorer survival with shorter RFS than ICC (P = 0.009).

CONCLUSION

The predominant histopathological component is closely related to the imaging manifestation of cHCC-CC; and more importantly, it plays a significant prognostic role, which may alter the RFS prognosis of cHCC-CC.

摘要

目的

探讨混合型肝细胞癌-胆管细胞癌(cHCC-CC)中主要成分在 MRI 表现方面的意义及其与肝细胞癌(HCC)和肝内胆管细胞癌(ICC)相比的潜在预后价值。

材料与方法

本研究回顾性分析了来自两个中心的 300 例慢性肝病患者,其中包括 100 例经手术证实的 cHCC-CC、HCC 和 ICC 各 100 例。采用单因素和多因素回归分析,确定区分 HCC 为主型 cHCC-CC 和 ICC 为主型 cHCC-CC 与 HCC 和 ICC 的独立预测因素。基于独立特征构建诊断模型。估计并比较各组的无复发生存率(RFS)。

结果

主要成分是 cHCC-CC 中 RFS 的独立预测因素(危险比=1.957,P=0.044)。靶样外观(优势比(OR)=10.907,P=0.001)、缺乏增强包膜(OR=0.072,P=0.001)和动脉肿瘤周强化(OR=0.091,P=0.003)是提示 HCC 为主型 cHCC-CC 与 HCC 相比的独立预测因素;它们的组合获得了 0.756 的曲线下面积。HCC 为主型 cHCC-CC 与 HCC 之间的 RFS 无显著差异(P=0.864)。男性(OR=4.049,P=0.015)、较高的甲胎蛋白(OR=16.789,P<0.001)和正常的碳水化合物抗原 19-9(OR=0.343,P=0.036)水平、增强包膜的存在(OR=7.819,P<0.001)和出血(OR=23.526,P=0.004)、以及缺乏靶样外观(OR=0.129,P=0.005)和肝表面回缩(OR=0.190,P=0.021)是提示 ICC 为主型 cHCC-CC 与 ICC 相比的独立预测因素;它们的组合获得了 0.898 的曲线下面积值。ICC 为主型 cHCC-CC 的 RFS 较短,生存时间较差,无复发生存率(RFS)低于 ICC(P=0.009)。

结论

主要组织病理学成分与 cHCC-CC 的影像学表现密切相关;更重要的是,它具有显著的预后作用,可能改变 cHCC-CC 的 RFS 预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验